2015

• Kameda T, Shide, Yamaji T, Kamiunten A, Sekine M, Taniguchi Y, Hidaka T, Kubuki Y, Shimoda H, Marutsuka K, Sashida G, Aoyama K, Yoshimitsu M, Harada T, Abe H, Miike T, Iwakiri H, Tahara Y, Sueta,M, Yamamoto S, Hasuike S, Nagata K, Iwama A, Kitanaka A, and Shimoda K. Loss-of-TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator. Blood. (125) 304-315, 2015.
• Kawada H, Yoshimitsu M, Nakamura D, Arai A, Hayashida M, Kamada Y, Maekawa K, Fujino S, Arima M, Arima N, Tabuchi T, Inoue H, Hamda H, Suzuki S, Matsushita K, and Arima N. A retrospective analysis of treatment outcomes in aggressive adult T cell leukemia/lymphoma patients treated with or without allogeneic stem cell transplantation: A single center experience. Biology of Blood and Marrow Transplantation. (21) 696-700, 2015.
• Yoshimitsu M, Higuchi K, Arima N, Medin JA, Takenaka T. Successful induction of pluripotent stem cells from a Fabry disease mouse model: Toward the development of safe lentiviral gene therapy. Journal of Stem Cell Research and Therapy. In press, 2015.
• Dworski S, Berger A, Furlonger C, Moreau JM, Yoshimitsu M, Trentadue J, Au BC, Paige CJ, Medin JA. Markedly perturbed hematopoiesis in acid ceramidase deficient mice. Haematologica. 2015 Feb 14.